Medilux Pharma Llp - Company Profile

It is a pharma limited liability partnership based in Indore, Madhya Pradesh, India, established in 2021.
2021 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Medilux Pharma Llp

Medilux Pharma Llp, a active limited liability partnership, was established on 09 September 2021 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAY-5266. Registered under ROC Roc Gwalior. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Sanjay Kanhiyalal Kewalramani (Designated Partner), Verkha Deepak Kewalramani (Designated Partner), Arshia Sanjay Kewalramani (Designated Partner). Its latest date of accounts and solvency statement 31 March 2025. It is based at 301, 3Rd Floor 384/1, Pushpratan Landmark Saket Nagar, Indore, Madhya Pradesh, 452001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAY-5266

  • Incorporation Date

    09 September 2021

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Gwalior

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 4 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Medilux Pharma Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Medilux Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Medilux Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Sanjay Kanhiyalal Kewalramani Designated Partner 09 Sep 2021 Current
Verkha Deepak Kewalramani Designated Partner 09 Sep 2021 Current
Arshia Sanjay Kewalramani Designated Partner 09 Sep 2021 Current
Deepak Kanhiyalal Kewalramani Designated Partner 09 Sep 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medilux Pharma Llp.

Enhance accessibility to Medilux Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Medilux Pharma Llp revenue growth over time
Medilux Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medilux Pharma Llp?

Unlock access to Medilux Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Medilux Pharma Llp?

Unlock and access historical data on people associated with Medilux Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medilux Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medilux Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medilux Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Medilux Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    The activity Medilux Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was completed.

  • Director Appointment

    Sanjay Kanhiyalal Kewalramani was appointed as a Designated Partner was appointed as a Designated Partner on 09 Sep 2021 & has been associated with this company since 4 years 8 months . was recorded as a recent event.

  • Director Appointment

    Verkha Deepak Kewalramani was appointed as a Designated Partner was appointed as a Designated Partner on 09 Sep 2021 & has been associated with this company since 4 years 8 months . was recorded as a recent event.

  • Director Appointment

    The activity Arshia Sanjay Kewalramani was appointed as a Designated Partner was appointed as a Designated Partner on 09 Sep 2021 & has been associated with this company since 4 years 8 months . was completed.

  • Director Appointment

    Progress on Deepak Kanhiyalal Kewalramani was appointed as a Designated Partner was appointed as a Designated Partner on 09 Sep 2021 & has been associated with this company since 4 years 8 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Medilux Pharma Llp?

The LLPIN of Medilux Pharma Llp is AAY-5266.

Where is Medilux Pharma Llp headquartered?

Medilux Pharma Llp is headquartered at 301, 3Rd Floor 384/1, Pushpratan Landmark Saket Nagar, Indore, Madhya Pradesh, 452001.

When was Medilux Pharma Llp incorporated?

Medilux Pharma Llp was incorporated on 09 September 2021.

Who are the current directors of Medilux Pharma Llp?

The current directors of Medilux Pharma Llp are

What is the primary industry of Medilux Pharma Llp?

The primary industry of Medilux Pharma Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available